Effectiveness for macular pigment with lutein supplementation in central serous chorioretinopathy
Not Applicable
- Conditions
- Central serous chorioretinopathy
- Registration Number
- JPRN-UMIN000005849
- Lead Sponsor
- Department of Ophthalmology, Osaka Univeristy Medical School
- Brief Summary
In a 4-month placebo-controlled study with 20-mg lutein supplementation, macular pigment optical density (MPOD) did not increase in central serous chorioretinopathy (CSC). Lutein supplementation maintained the MPOD in CSC patients with low plasma lutein.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Hard exudate or subretinal hemorrhage within subretinal fluid 2)Invisible fundus 3)Visual acuity less than 0.01 4)Difficulty to measure macular pigment 5)After vitrectomy 6)Past supplementaion with lutein
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method macular pigment and serum lutein
- Secondary Outcome Measures
Name Time Method